Charles G. Phillips III, Director at NovoCure Ltd (NVCR), sold 12,290 shares at $88.11 ($1.1M) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Open-market sale of $1.1M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.11 | 6,145 | $541K | 50.0% |
| 2 | $88.11 | 6,145 | $541K | 50.0% |
| Total | $88.11 avg | 12,290 | $1.1M | 100% |
| Filing → |
| NVCR | SELL | 2018-05-30 | $1.5M | — | Filing → |